| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |